Mechanism of toxic action of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD) in cultured human luteinized granulosa cells

Reproductive Toxicology

Volumn 10, Issue 6, 1996, Pages 497-508

  Enan, Essam ^a,b   Moran, Francisco ^b   VandeVoort, Catherine A ^b,c   Stewart, Dennis R ^c   Overstreet, James W ^a,b,c   Lasley, Bill L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

activator protein 1 (AP 1); EGFR; human luteinized granulosa cells; protein phosphorylation; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXIMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; HALOGENATED HYDROCARBON; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL CULTURE; CELL CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; ESTROGEN RELEASE; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; METABOLISM; MITOSIS; PROTEIN PHOSPHORYLATION; REPRODUCTION; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

CELL CYCLE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ESTRADIOL; FEMALE; GRANULOSA CELLS; HUMANS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

EID: 0030293741     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(96)00137-2     Document Type: Article

References (46)

1. 1. Poland A, Kimbrough RD, eds. Biological mechanisms of dioxin action. Banbury Report 18. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1984.
2. 2. Poland A, Kende A. The genetic expression of aryl hydrocarbon hydroxylase activity: evidence for a receptor mutation in nonresponsive mice. In Hiatt HH, Watson SD, Winsten JA, eds. Origins of human cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1977:847.
3. 3. Barsotti DA, Abrahamson LJ, Allen JR. Hormonal alterations in female rehesus monkeys fed a diet containing 2,3,7,8-tetrachlorodibenzo-p-dioxin. Bull Environ Contam Toxicol. 1979; 21:463-8.
4. 4. Romkes M, Piskorska-Pliszcnska J, Safe S. Effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol Appl Pharmacol. 1987;87:306-10.
5. 5. Astroff B, Eldridge B, Safe S. Inhibition of the 17β-estradiol-induced and constitutive expression of the cellular proto-oncogene c-fos by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the female rat uterus, Toxicol Lett. 1991;56:305-9.
6. 6. Reese JC, Katzenellenbogen BS. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Nucleic Acids Res. 1991;19:6595-6602.
7. 7. Migliaccio A, Pagano M, Auricchio F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 1993;8:2183-91.
8. 8. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science. 1991;254:1636-9.
9. 9. Murayama Y, Kurata S, Mishim Y. Regulation of human estrogen receptor gene, epidermal growth factor receptor gene, and oncogenes by estrogen and antiestrogen in MCF-7 breast cancer cells. Cancer Detect Prevent. 1988;13:103-7.
10. 10. Lamb P, Mcknight SL. Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem Sci. 1991;16:417-22.
11. 11. Miner JN, Yamamoto KR. Regulatory crosstalk at composite response elements. Trends Biochem Sci. 1991;16:423-6.
12. 12. Wagner S, Green MR. A transcriptional tryst. Nature. 1991;352: 189-90.
13. 13. Smith DF, Toft DO. Steroid receptors and their associated proteins. Mol Endocrinol. 1993;7:4-11.
14. 14. Fawell SE, Lees JA, White R, Parker MG. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell. 1990;60:953-62.
15. 15. Denton RR, Koszewski NJ, Notides AC. Estrogen receptor phosphorylation: hormonal dependence and consequence on specific DNA Binding. J Biol Chem. 1992;267:7263-8.
16. 16. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr Rev. 1993;14: 651-8.
17. 17. Krishnan V, Wang X, Safe S. Estrogen receptor-SP-1 complexes mediate estrogen-induced calhepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem. 1994;269:15912-7.
18. 18. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshall CJ. Activation of the MAP kinase pathway by the protein kinase raf. Cell. 1992;71:335-42.
19. 19. Chen RH, Sarneck C, Blenis J. Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Mol Cell Biol. 1992;12: 915-21.
20. 20. Kyriakis JM, App H, Zhang X-F, Banerjee P, Brautigan DL, Rapp UR, Avruch J. Raf-1 activates MAP kinase-kinase. Nature. 1992; 358:417-21.
21. 21. Enan E, Matsumura F. Evidence for a second pathway in the action mechanism of TCDD: significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem Pharmacol. 1995;49:249-61.
22. 22. Hunter T, Sefton B. Cooperation between oncogenes. Cell. 1991; 64:249-70.
23. 23. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990;61:203-12.
24. 24. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzeger D, Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995;270: 1491-4.
25. 25. Enan E, Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the TC-DD's signal through protein phosphorylation pathway. Biochem Pharmacol. 1996 (in press).
26. 26. Dignam JD, Lebovitz RM, Roeder RG. Accurate transciption initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res. 1983;11:1475-89.
27. 27. Enan E, Matsumura F. Significance of TCDD-induced protein phosphorylation in the adipocyte of male guinea pigs. J Biochem Toxicol. 1994;9:159-70.
28. 28. Clark-Lewis I, Sanghera JS, Pelech SL. Definition of a consensus sequence for peptide substrate recognition by p44 mpk, the meiosis-activated myelin basic protein kinase. J Biol Chem. 1991;266;15180-4.
29. 29. Enan E, Matsumura F. Regulation of AP-1 activity by TCDD through nuclear protein phosphorylation in adipose tissue of guinea pig. Biochem Pharmacol. 1995;50:1199-1206.
30. 30. Matsumura F, Madhukar BV, Bombick DW, Brewster DW. Toxicological significance of pleiotropic changes of plasma membrane functions particularly that of EGF receptor caused by 2,3,7,8-TCDD. In Banbury Report 18: Biological mechanisms of dioxin action. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1985:267.
31. 31. Lin FH, Clark G, Birnbaum LS, Lucier GW, Goldstein JA. Influnce of Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Mol Pharmacol. 1991;39:307-13.
32. 32. Meek DW, Street AJ. Nuclear protein phosphorylation and growth control. Biochem J. 1992;287:1-15.
33. 33. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem. 1991;60:281-319.
34. 34. Durrin LK, Whitlock JP Jr. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inducible aryl hydrocarbon receptor-mediated binding of enhancer DNA. J Biol Chem. 1989;265:5718-21.
35. 35. Hurst BS, Zilberstein M, Chou JY, Litman B, Stephens J, Leslie KK. Estrogen receptor are present in human granulosa cells. J Clin Endocrinol Metab. 1995;80:229-32.
36. 36. Enan E, Matsumura F. 2,3,7,8-tetrachlorodibenzo-p-dioxin induced alterations in protein phosphorylation in guinea pig adipose tissue. J Biochem Toxicol. 1993;8:89-99.
37. 37. Katoh S, Funayama A, Kohno H, Ohkubo Y. Dephosphorylation on tyrosine of epidermal growth factor receptor is inhibited by calcium pretreatment in isolated liver membrane. Arch Biochem Biophys. 1993;307:52-6.
38. 38. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgil TW. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3,′5′-monophosphate. Science. 1993;262:1065-9.
39. 39. Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science. 1993;262:1069-72.
40. 40. Anderson NG, Maller JL, Tonks NK, Sturgill TW. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature. 1990;343:651-3.
41. 41. Blumer KJ, Johnson GL. Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci. 1994;19:236-40.
42. 42. Stevetson BR, Kong X, Lawrence, JC Jr. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA. 1993;90:10305-9.
43. 43. Avruch J, Xhang X-F, Kyriakis JM. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci. 1994;19:279-84.
44. 44. Hershowitz I. MAP kinase pathways in Yeast: for mating and more. Cell. 1995;80:187-96.
45. 45. Marshall, CJ. Specificity of receptor tyrosine kinase signaling, transient vs. sustained extracellular signal-regulated kinase activation. Cell. 1995;80:179-90.
46. 46. Mais V, Kazer RR, Cetel NS, Rivier J, Vale W, Yen SSC. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe. J Clin Endocrinol Metabol. 1986;62:1250-8.